Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells

The Journal of Biological Chemistry
H J ListA T Riegel

Abstract

Human breast tumorigenesis is promoted by the estrogen receptor pathway, and nuclear receptor coactivators are thought to participate in this process. Here we studied whether one of these coactivators, AIB1 (amplified in breast cancer 1), was rate-limiting for hormone-dependent growth of human MCF-7 breast cancer cells. We developed MCF-7 breast cancer cell lines in which the expression of AIB1 can be modulated by regulatable ribozymes directed against AIB1 mRNA. We found that depletion of endogenous AIB1 levels reduced steroid hormone signaling via the estrogen receptor alpha or progesterone receptor beta on transiently transfected reporter templates. Down-regulation of AIB1 levels in MCF-7 cells did not affect estrogen-stimulated cell cycle progression but reduced estrogen-mediated inhibition of apoptosis and cell growth. Finally, upon reduction of endogenous AIB1 expression, estrogen-dependent colony formation in soft agar and tumor growth of MCF-7 cells in nude mice was decreased. From these findings we conclude that, despite the presence of different estrogen receptor coactivators in breast cancer cells, AIB1 exerts a rate-limiting role for hormone-dependent human breast tumor growth.

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M Gossen, H Bujard
May 1, 1983·European Journal of Cancer & Clinical Oncology·R L SutherlandI W Taylor
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·B HansteinM Brown
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·A M SchulteA Wellstein
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·H LiJ D Chen
Apr 16, 1998·Breast Cancer Research and Treatment·E M BernsJ A Foekens
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·W S ShimM H Jeng
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·C QiJ K Reddy
Sep 15, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y ZhuJ K Reddy
Mar 14, 2000·Gene·C Leo, J D Chen
Sep 30, 2000·The Journal of Biological Chemistry·D ChenM R Stallcup
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·M K TikkanenF E Murdoch
Nov 23, 2000·Proceedings of the National Academy of Sciences of the United States of America·Z WangM G Rosenfeld
Nov 30, 2000·FEBS Letters·S WerbajhM A Costas
Oct 27, 2001·Breast Cancer Research and Treatment·H J ListA T Riegel

❮ Previous
Next ❯

Citations

Feb 10, 2009·International Journal of Colorectal Disease·Petros D GrivasHaralabos Kalofonos
May 7, 2009·Breast Cancer Research and Treatment·Tyler LahusenAnna T Riegel
Mar 26, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Lan LiaoJianming Xu
Dec 9, 2003·The Breast : Official Journal of the European Society of Mastology·C Kent Osborne, Rachel Schiff
Dec 9, 2003·The Breast : Official Journal of the European Society of Mastology·V C JordanHong Liu
Aug 25, 2009·Nature Reviews. Cancer·Jianming XuBert W O'Malley
Jul 23, 2011·Nature Reviews. Cancer·Christoforos Thomas, Jan-Åke Gustafsson
Jul 25, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S AlknerUNKNOWN Swedish and South-East Swedish Breast Cancer Groups
Mar 6, 2003·Journal of the National Cancer Institute·V Craig Jordan
Mar 6, 2003·Journal of the National Cancer Institute·C Kent OsborneRachel Schiff
Mar 17, 2006·Acta Pharmacologica Sinica·Jun YanMing-Jer Tsai
Aug 31, 2006·Molecular and Cellular Biology·Anwar HossainGrady F Saunders
Jul 22, 2009·Molecular and Cellular Biology·Stephanie J Ellison-ZelskiElaine T Alarid
Aug 12, 2005·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Wei Xu
Sep 15, 2011·BMC Biochemistry·Dale CorkeryJoseph Torchia
Feb 26, 2010·Molecular Endocrinology·Rainer B LanzBert W O'Malley
Feb 5, 2011·Molecular Endocrinology·Rebecca E NaklesPriscilla A Furth
Nov 5, 2011·Molecular Endocrinology·Ying WangBert W O'Malley
Aug 12, 2008·International Journal of Biological Sciences·Zhaoliang LiuJianming Xu
Jun 15, 2014·Steroids·Ifeyinwa E ObiorahV Craig Jordan
Nov 10, 2001·Trends in Endocrinology and Metabolism : TEM·L Altucci, H Gronemeyer
Sep 9, 2015·Endocrine-related Cancer·Penn Muluhngwi, Carolyn M Klinge
Aug 10, 2004·Surgery·Christopher B WeldonMatthew E Burow
May 18, 2004·The Journal of Steroid Biochemistry and Molecular Biology·Dalei ShaoDonald E Frail
May 1, 2012·Biomolecules & Therapeutics·Minsun Chang
Aug 29, 2012·Expert Opinion on Therapeutic Targets·Jean Ching-Yi Tien, Jianming Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.